Your browser doesn't support javascript.
loading
Hand in hand to successful immunotherapy: CD8+ T cells and M1-like macrophages swap the baton.
Hussein, Abir; Stamova, Slava; Xydia, Maria; Beckhove, Philipp.
Afiliación
  • Hussein A; Leibniz Institute for Immunotherapy, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
  • Stamova S; Leibniz Institute for Immunotherapy, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
  • Xydia M; Leibniz Institute for Immunotherapy, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Bavarian Cancer Research Center (BZKF), University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
  • Beckhove P; Leibniz Institute for Immunotherapy, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany. Electronic address: beckhove@rcii.de.
Cancer Cell ; 42(6): 938-941, 2024 Jun 10.
Article en En | MEDLINE | ID: mdl-38861930
ABSTRACT
Cancer immunotherapy is a pillar of clinical oncology but only achieves long-term remissions in a minority of cases. In this issue, van Elsas et al. show that effective immunotherapy requires a series of processes orchestrated by CD8+ T cells that result in the recruitment and local activation of M1-like macrophages.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Inmunoterapia / Macrófagos Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Inmunoterapia / Macrófagos Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article